1 – 10 of 66
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Depressive Symptoms and Amyloid Pathology
- Contribution to journal › Article
-
Mark
Updated appropriate use criteria for amyloid and tau PET : A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Contribution to journal › Scientific review
-
Mark
Recent advances in neuroimaging of Alzheimer's disease and related dementias
- Contribution to journal › Scientific review
-
Mark
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
- Contribution to journal › Article
-
Mark
Clinical Performance of the Elecsys CSF pTau181/Aβ42 Ratio for Concordance with Tau-PET in Two Independent Cohorts
- Contribution to journal › Article
-
Mark
Treatment-related amyloid clearance (TRAC) : a framework to characterize patients in the era of anti-amyloid therapies
- Contribution to journal › Debate/Note/Editorial
- 2024
-
Mark
Influence of different time framings, reconstruction algorithms and post-processing methods on the quantification of myocardial blood flow from 13N-NH3 PET images
- Contribution to journal › Article
-
Mark
How Do Modifiable Risk Factors Affect Alzheimer's Disease Pathology or Mitigate Its Effect on Clinical Symptom Expression?
- Contribution to journal › Scientific review
-
Mark
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium
- Contribution to journal › Article
-
Mark
Survey among experts on the future role of tau-PET in clinical practice and trials
- Contribution to journal › Article
